Drug Discovery technologies support target identification, screening, modelling, and candidate optimisation in pharmaceutical and biotech research. Organisations use them to accelerate R&D, improve decision-making, and shorten parts of the discovery cycle.
Increase visibility within this niche through featured placement and targeted discovery.
Includes logo placement, enhanced visibility and association with this subcategory.
Already listed? Claim and upgrade your provider profile.
An example of an Enhanced Profile. Enhanced providers get expanded detail, compliance signalling and direct contact — this shows how an upgraded listing appears in the directory.
Not a real provider — shown to illustrate the Enhanced Profile.
Ablynx was a Belgian biotechnology company developing nanobody-based therapies. It was acquired by Sanofi in 2018 and its nanobody platform continues to generate new medicines.
Addex Therapeutics is a Swiss clinical-stage biotechnology company developing allosteric modulator drugs for neurological and metabolic diseases.
Alfasigma Digital develops pharmaceutical digital distribution platforms, patient digital services and regulatory compliance tools for Alfasigma's Italian and European specialty pharmaceutical business.
Alkaloid Digital develops pharmaceutical manufacturing analytics and digital supply chain management for Alkaloid's Macedonian and Southeast European generic pharmaceutical and cosmetics business.
Almirall is a Spanish pharmaceutical company specialising in dermatology and respiratory medicines, with R&D and commercial operations across Europe. The company is majority-owned by the…
AM-Pharma is a Dutch biopharmaceutical company developing innovative treatments for organ failure and inflammatory conditions in critical care settings.
Angelini Pharma is an Italian family-owned pharmaceutical company focusing on CNS, rare diseases, and consumer health products across European markets.
Aqemia is a French AI drug discovery company using quantum-inspired statistical mechanics to predict molecular properties and design novel drug candidates for pharmaceutical clients.
argenx is a Dutch global immunology company developing antibody-based treatments for severe autoimmune diseases. It is listed on Nasdaq and Euronext Brussels.
Arrels Therapeutics is a Spanish biotech company developing first-in-class small molecule therapeutics targeting epigenetic mechanisms for oncology and rare disease indications.
AstraZeneca Digital develops AI drug discovery capabilities, clinical trial digitalisation and real-world evidence platforms for AstraZeneca's global oncology and biopharmaceutical research.
Autolus Digital develops T-cell therapy manufacturing analytics, digital clinical operations platforms and patient monitoring tools for Autolus's CAR T-cell therapy development pipeline.
Axonal Biostratech is a French clinical CRO providing digital clinical trial management, regulatory submission platforms and biostatistics tools for pharmaceutical and biotech companies.
B. Braun is a German family-owned medical technology company producing infusion therapy products, surgical instruments, and dialysis equipment for healthcare providers globally.
Bavarian Nordic Digital develops clinical trial data management, vaccine production analytics and digital patient access platforms for Bavarian Nordic's global vaccine development operations.
Bayer Digital develops AI-powered drug discovery platforms, digital health solutions and precision medicine tools for Bayer's pharmaceutical and consumer health divisions globally.
Beneo Digital develops functional ingredient formulation analytics and digital nutritional intelligence platforms for Beneo's global chicory root and cereal-based nutrition ingredient business.
Benevolent AI is a British clinical-stage AI drug discovery company using machine learning to identify novel disease mechanisms and generate therapeutic hypotheses for unmet medical…
BenevolentAI is a British AI company applying machine learning to drug discovery, analysing biomedical data to identify novel drug targets and treatment hypotheses.
bioMérieux is a French in vitro diagnostics company producing microbiology, immunoassay, and molecular diagnostic systems used in hospitals and laboratories. Majority-controlled by the French Mérieux…
Biotage is a Swedish life science tools company providing purification, evaporation, and organic chemistry instruments for pharmaceutical and environmental analysis.
BioVersys is a Belgian antibiotic discovery company developing novel antibacterial compounds against drug-resistant infections using digital compound screening and target identification platforms.
Bosnalijek Digital develops pharmaceutical manufacturing analytics, digital quality management and supply chain traceability platforms for Bosnalijek's Bosnian and regional generic medicines business.
BRT Laboratories is an Italian clinical research organisation providing phase I-IV trial management, digital pharmacovigilance and regulatory submission tools for pharmaceutical companies.
Chiesi Farmaceutici is an Italian family-owned pharmaceutical company focusing on respiratory, rare diseases, and neonatology. It is a certified B Corporation.
Chr. Hansen Digital develops microbial fermentation analytics, digital culture management and food biotech process intelligence for Chr. Hansen's global natural ingredient technology business.
Corbion Digital develops biobased materials informatics, fermentation process intelligence and digital formulation tools for Corbion's global biochemical and biopolymer ingredients business.
Cradle is a Swiss AI company applying generative AI to protein and drug design, enabling biotech researchers to engineer biological molecules faster using machine learning.
CureVac Digital develops mRNA formulation analytics, clinical immunogenicity data platforms and digital manufacturing tools for CureVac's global RNA therapeutics and vaccine development.
Dechra Digital develops veterinary pharmaceutical digital distribution platforms, clinical data analytics and digital customer service tools for Dechra's global specialist veterinary medicines business.
dsm-firmenich Digital develops precision fermentation analytics, digital flavour and fragrance formulation tools and biotech process intelligence for its global nutrition and beauty ingredients business.
Euroapi is a French active pharmaceutical ingredient company providing API manufacturing, digital batch traceability and regulatory compliance tools for European pharmaceutical manufacturers.
Evotec is a German drug discovery and development company providing integrated services and partnerships with pharmaceutical companies to accelerate drug discovery programmes.
Formo is a German precision fermentation company developing animal-free dairy proteins to produce cheese and dairy products without cows for the alternative protein market.
Galapagos is a Belgian clinical-stage biotechnology company developing novel therapies for diseases with high unmet medical need, particularly inflammatory and fibrotic conditions.
Gedeon Richter Digital develops women's health digital therapeutic platforms, fertility tracking tools and connected patient support systems for Richter's global reproductive health pharmaceutical business.
Genmab Digital develops antibody drug discovery analytics, digital clinical trial management and bioinformatics platforms for Genmab's global differentiated antibody therapeutic development pipeline.
GSK Digital develops AI drug target identification, digital clinical trial platforms and connected patient health monitoring systems for GSK's global pharmaceutical and vaccine research pipeline.
Grifols is a Spanish family-controlled pharmaceutical company producing plasma-derived medicines, hospital diagnostics, and transfusion medicine products globally.
Guerbet is a French specialty pharmaceutical company focused on contrast agents and medical imaging solutions used in radiology. The company is majority-controlled by the French…
Healx is a British AI-powered drug repurposing company using machine learning to identify existing approved drugs that can be repositioned to treat rare and orphan…
Heidelberg Pharma Digital develops antibody-drug conjugate development platforms and digital preclinical analytics for its proprietary ATAC technology in cancer treatment drug development.
Heraeus Digital develops precious metal materials informatics, digital refining analytics and connected manufacturing platforms for Heraeus's global precious metals, sensors and biomaterials business.
ICON Digital develops clinical trial data management, digital biomarker analytics and regulatory submission platforms for ICON's global contract research and clinical development services.
Idorsia is a Swiss biopharmaceutical company spun out of Actelion, discovering and developing drugs for diseases with high unmet medical need including sleep disorders and…
Immunocore Digital develops ImmTAX bispecific therapy analytics, digital clinical trial management and patient outcome monitoring platforms for Immunocore's T-cell receptor oncology pipeline.
Inato is a French clinical trial marketplace connecting pharmaceutical sponsors with a global network of research sites to accelerate patient recruitment for clinical studies.
Ipsen is a French biopharmaceutical company focused on oncology, rare diseases, and neuroscience with a growing portfolio of specialty medicines.
Krka Digital develops generic pharmaceutical manufacturing analytics, digital regulatory compliance tools and supply chain traceability platforms for Krka's European and global generic medicines business.
Leo Pharma is a Danish family foundation-owned pharmaceutical company specialising in dermatology, providing treatments for psoriasis, eczema, and wound care.
Lonza Digital develops biopharmaceutical process analytics, digital CDMO platforms and quality management systems for Lonza's global contract development and manufacturing operations.
Lundbeck is a Danish pharmaceutical company focused on brain diseases, producing treatments for depression, schizophrenia, Parkinson's, and Alzheimer's disease.
Menarini is an Italian family-owned pharmaceutical company producing drugs for cardiovascular, respiratory, and infectious disease across European and global markets.
Menarini Digital develops pharmaceutical commercial data analytics, digital patient support tools and regulatory compliance platforms for Menarini's European and global prescription drug operations.
Merus is a Dutch clinical-stage oncology company developing bispecific antibody treatments using its Biclonics technology platform for cancer patients.
MorphoSys is a German biopharmaceutical company developing antibody-based treatments for cancer and autoimmune diseases. It was acquired by Novartis in 2024.
Nanoform is a Finnish pharmaceutical nanotechnology company providing particle engineering services to improve the bioavailability and efficacy of poorly soluble drug compounds.
Novartis is a Swiss global pharmaceutical company developing medicines across oncology, neuroscience, and immunology. The company is listed on the SIX Swiss Exchange and has…
Novo Nordisk Digital develops AI drug discovery capabilities, digital clinical operations and connected diabetes device platforms for Novo Nordisk's global pharmaceutical operations.
Nuritas is an Irish AI-powered bioactive discovery company using deep learning to identify and unlock health-promoting peptides from natural food sources for pharma and food…
EuropeanSwitch enables organisations to position themselves within key sectors and categories across Europe.